The Wild West of American Commercial Surrogacy

The Boom of Commercial Surrogacy and the Regulatory Vacuum

American commercial surrogacy operates largely without federal regulation, leaving governance entirely to individual states. According to data from the Society for Assisted Reproductive Technology, 11,821 embryos were transferred to gestational carriers in member clinics in 2024, rising from 8,461 three years prior. This expansion has been fueled significantly by aspiring parents, including same-sex male couples utilizing organizations such as Men Having Babies.

However, the lack of centralized oversight creates profound legal and ethical vulnerabilities. As detailed in legal analyses from Macias Valley Law, state laws diverge sharply. While California actively promotes and facilitates commercial arrangements, states like Michigan maintain strict bans, rendering compensation-based contracts entirely unenforceable and occasionally criminal. This jurisdictional friction leaves participants dependent on the specific inclinations of local courts when disputes arise.

To safely manage these complex multi-state agreements, prospective parents and carriers frequently rely on specialized legal infrastructure.

Contrasting Global Frameworks: Prohibition Versus Permissive Markets

The United States stands out globally for its permissive stance on commercial surrogacy. In contrast, every country in the European Union has banned the practice. French President Emmanuel Macron has characterized commercial surrogacy as incompatible with women’s dignity, while Italy imposes severe penalties, including fines up to 1 million euros and potential jail time for citizens who utilize overseas surrogacy.

Developing nations have similarly reacted to exploitation risks. Thailand banned commercial surrogacy in 2015 following high-profile international scandals, and Kazakhstan recently moved to ban foreign surrogacy. Meanwhile, agencies in Ukraine, such as BioTexCom, continue to coordinate international surrogacy journeys, though operations face ongoing geopolitical and logistical challenges.

The Human Cost: Carrier Risks and Oversight Deficits

While industry marketing often portrays surrogacy as a universally uplifting journey, individual accounts reveal significant physical and emotional tolls. Gestational carriers take on substantial medical risks. A 2024 Ontario study of over 850,000 pregnancies indicated that severe maternal morbidity rates can be significantly higher among gestational carriers compared to conventional pregnancies, potentially driven by immunological factors when the fetus is genetically unrelated to the carrier.

Furthermore, regulatory omissions mean that vetting processes for intended parents rarely match the rigorous background checks required in traditional adoption. Incidents involving individuals with criminal records or inadequate domestic support systems commissioning children highlight systemic vulnerabilities. Organizations such as the Center for Bioethics and Culture Network frequently report handling cases where carriers face unexpected medical debt, inadequate mental health support, or restrictive nondisclosure agreements.

Navigating the psychological and medical aftermath of a complicated surrogacy arrangement requires dedicated professional intervention.

The commercial surrogacy market continues to expand rapidly across the United States, balancing life-creating aspirations against profound regulatory and ethical uncertainties. Without uniform national standards, the safety and legality of each arrangement depend almost entirely on private contracts, local court discretion, and the variable oversight of commercial agencies.